"Evaluating the susceptibility of MBL carbapenemase-producing Enterobacteriaceae and Pseudomonas spp. to ceftazidime/avibactam plus aztreonam and Cefiderocol: A synergy study and susceptibility profile"
{{output}}
This study assessed the in vitro susceptibility of aztreonam/avibactam (ATM/AVI) and the synergy analyses against 38 clinical carbapenemase-producing strains (31 Enterobacterales and 7 Pseudomonas spp.) collected over two years. Susceptibility testing were per... ...
